Crossmark

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Crossref DOI link: https://doi.org/10.1038/s41422-020-0305-x

Published Online: 2020-03-30

Published Print: 2020-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xia, Shuai

Liu, Meiqin

Wang, Chao

Xu, Wei

Lan, Qiaoshuai http://orcid.org/0000-0001-5524-3542
Feng, Siliang

Qi, Feifei

Bao, Linlin

Du, Lanying

Liu, Shuwen

Qin, Chuan

Sun, Fei http://orcid.org/0000-0002-0351-5144
Shi, Zhengli

Zhu, Yun

Jiang, Shibo

Lu, Lu http://orcid.org/0000-0002-2255-0391
License Information

Text and Data Mining valid from 2020-03-30

Version of Record valid from 2020-03-30
More Information

Article History

Received: 25 February 2020

Accepted: 10 March 2020

First Online: 30 March 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below